Expertise, Role and Activity
At EMC, the Rotterdam Study, an observational population-based cohort study, started in 1990 and contains >17.000 individuals. The study aims to unravel etiology, preclinical course, natural history and potential targets for intervention for chronic diseases, such as atherosclerosis, in mid- and late-life.
EMC is an essential consortium partner to study biomarkers for CVD, as all relevant clinical parameters and blood/serum samples from a large general population cohort taken over the years are available, required for WP3, in close collaboration with ULUND.
With the Rotterdam study, B-specific consortium will be able to critically assess the predictive values of potential biomarkers for atherosclerosis.
The team at EMC is composed of 3 PIs, their expertise is vital for the execution of WP4 of B-specific.
Maryam Kavousi
Dr. Maryam Kavousi - expert in the field of cardiovascular epidemiology
Arkan Ikram
Dr. Arkan Ikram - expert in epidemiology
Joyce van Meurs
Prof. Joyce van Meurs - expert on integrative genomics in population cohorts
All the Consortium
